A carregar...
Ipilimumab in prostate cancer
INTRODUCTION: Immune checkpoint inhibitors, such as ipilimumab, are a new class of immunotherapeutic agents that have shown significant efficacy in melanoma. A number of ongoing clinical trials are investigating the role of ipilimumab in prostate cancer, either alone or in combination with immunomod...
Na minha lista:
| Publicado no: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628899/ https://ncbi.nlm.nih.gov/pubmed/23265575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2012.754421 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|